Senior Quality Systems Engineer

Organization
Illumina
Job Location
Santa Clara, CA 95050
Salary
Competitive
Benefits

Competitive

Job Description

I hope this finds you happy, smiling and enjoying the day.

The reason for this message is to make you aware of an exciting opportunity for a Quality Systems Engineer with Illumina. The passion and drive of employees enables Illumina to take innovation to the next level.

 

This is a hands-on role where you will provide quality systems leadership, oversight and strategic guidance to driver initiatives and develop/improve procedures. Train and mentor teams to the usage QMS in their respective projects and functions.

Apply quality regulations and standards (21CFR, 820, ISO 13485, ISO 14971, IVDD, MDD) Experience with enterprise Quality System tools.

 

Illumina’s product lets you apply innovative technologies to the genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for Illumina to deliver innovative, flexible and scalable solutions to their customers.

We are working on a Cloud Platform for SaaS offerings.

Illumina’s software fuels groundbreaking advancements in life sciences research, translational and consumer genomics and molecular diagnostics. They specialize in and have the most comprehensive tools for modern genetic analysis.

Their products help scientists and researchers answer complex biological questions. This will allow the gain a better understanding of how to prevent, treat, and cure illness. Each day presents a new challenge.

 

About Our Organization

Headquartered in San Diego, California, Illumina (NASDAQ: ILMN), is a leading developer, manufacturer, and marketer of next generation life science tools and integrated systems for large-scale analysis of genetic variation and biological function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With the innovative advances in our sequencing technologies, we are rapidly impacting the clinical market in areas such as reproductive health and oncology. The expanding Illumina oncology portfolio of next- generation sequencing NGS and microarray technologies is revolutionizing cancer genomics research. Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.

lllumina has experienced phenomenal growth from $10 million in revenues in 2002 to over $1.4 billion in 2013. Forbes named Illumina #1 on the 2009 list of 25 Fastest-Growing Technology Companies in the United States, the second time over a three year period that Forbes ranked Illumina #1 on its list of rapidly growing technology companies. Illumina was also named #1 smartest company in the world as part of MIT’s 2014 Technology Review. As of August 2014, the company had a $24 billion market capitalization.

New study finds bias against female lecturers among student course evaluations, the Economist reports.

A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.